Tokyo Medical and Dental University   Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4
Founded: Tokyo Japan (1928)

Organization Overview

First Clinical Trial
2006
NCT00335985
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Dept. of Oral health promotion, Tokyo medical and dental university | Ei Ei Aung | Hitomi Mita | Tokyo Medical and Dental University

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Kidney Injury (Phase 4)

Carcinoma, Hepatocellular (Phase 4)

Cholangiocarcinoma (Phase 4)

Colonic Neoplasms (Phase 3)

Colorectal Neoplasms (Phase 3)

Crohn Disease (Phase 3)

Dermatomyositis (Phase 3)

Gallbladder Neoplasms (Phase 4)

Halitosis (Phase 4)

Lung Diseases, Interstitial (Phase 3)

Pneumonia (Phase 3)

Polymyositis (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 17